|
Indication |
Induction of active immunity against hepatitis B
virus |
|
Proprietary Name |
Engerix-B |
Recombivax HB |
|
Manufacturers |
GlaxoSmithKline |
Merck |
|
Viability |
Inactivated |
Inactivated |
|
Microorganism |
Double-stranded DNA hepatitis virus family
Hepadnaviridae |
Double-stranded DNA hepatitis virus family
Hepadnaviridae |
|
Dose: |
|
|
|
Adult |
20 mcg/mL |
10 mcg/mL |
|
Pediatric |
10 mcg/0.5 mL |
5 mcg/0.5 mL |
|
Dialysis |
|
40 mc/mL |
|
Route |
Intramuscular |
Intramuscular (for persons at risk of
hemorrhage, can be Subcutaneous) |
|
Dose form |
Suspension |
Suspension |
|
Appearance |
Slightly Turbid White Suspension |
Slightly opaque white after agitation |
|
Concentration |
20 mcg/mL |
10 or 40 mcg/mL depending on package |
|
Preservatives: |
Trace amount of Thimerosal |
None |
|
Adult |
< 1 mcg/mL mercury |
|
|
Pediatric |
< 0.5 mcg/mL mercury |
|
|
Adjuvant |
Aluminum Hydroxide, ≤ 0.5 mg/mL |
Aluminum Hydroxide, ≤ 0.5 mg/mL |
|
Excipients |
Disodium phosphate, 0.98 mg/mL
Sodium dihydrogen phosphate, 0.71 mg/mL
|
None |
|
Allergens |
Yeast protein, <5% or plasmid DNA |
Yeast protein, <1% |
|
Media |
Saccharomyces
cerevisiae |
Saccharomyces cerevisiae
grown in fermentation medium consisting of
yeast, soy peptone, dextrose, amino acids, and
mineral salts |
|
Packaging |
Vials and Prefilled TIP-LOK syringes |
0.5 mL and 1 mL single-dose vials |
|
Routine Storage |
2 to 8° C (36 to 46°
F).
Do not freeze |
2 to 8° C (36 to 46°
F).
Do not freeze |
|
updated July 2005 |